Letter to President Donald Trump - Senators Stabenow, Peters Call for Action to Prevent Counterfeiting, Price Gouging of Medical Supplies Amid COVID-19 Pandemic

Letter

Dear President Trump:

We write today to bring your attention to the serious impact that price gouging, as well as
fraudulent and counterfeit goods, are having on our country's ability to treat patients and combat
the spread of the COVID-19. We urge you to swiftly exercise the authorities at your disposal to
improve distribution channels, prevent fraud, and better protect patients, health care providers,
first responders, critical infrastructure workers, and all Americans.
Every day, profiteers and scam artists are taking advantage of desperate buyers and the
unprecedented demand for personal protective equipment by charging obscene prices and selling
counterfeit or fraudulent goods. Local and state governments, health care providers, first
responders, and affected critical industries are scrambling to find new or additional sources of
this equipment and, even worse, competing against each other for dwindling supplies.
When those buyers, struggling to replace their diminishing stocks, are forced to turn to
international suppliers outside their accustomed channels and dubious third-party brokers,
Americans are less safe. When health care providers pay outrageous, marked-up prices for
personal protective equipment, only to discover that they purchased counterfeit items, those
providers cannot safely and effectively do their jobs.
We implore you to exercise the strong manufacturing and supply channel oversight needed to
keep profiteers and counterfeiters from taking advantage of vulnerable Americans. In addition to
improving the integrity and oversight of personal protective equipment distribution to free the
national supply chain of counterfeit items, we also urge you to protect Americans by directing
national law enforcement and regulatory agencies to swiftly investigate allegations of
counterfeiting and price-gouging.
2
Your executive orders of March 18 and March 23, 2020 delegated authority to a number of
executive branch officials to take actions to prevent hoarding and to determine the "proper
nationwide priorities and allocation of all health and medical resources, including controlling the
distribution of such materials […] in the civilian market." The voluntary support from industry
and manufacturers that your administration has largely relied upon thus far is an important initial
step, and we are heartened by American businesses that are stepping up and working to meet the
challenge. However, in this crisis, volunteerism can neither equal nor replace a comprehensive,
efficient, and nationwide strategy designed to ensure that quality medical supplies are produced
and effectively distributed to areas of critical need.
We, therefore, respectfully urge that you develop a response that strategically manufactures,
allocates, and distributes medical supplies so as to prevent the introduction of counterfeit or
fraudulent personal protective equipment into the supply chain, prevent profiteering and price
gouging, and ensure that our local, state, and federal governments are all working together to
fight the pandemic, rather than being forced into competing with one another for critical medical
supplies.

Sincerely,